Tharimmune Inc Forgn. Eq (THAR) Financials
$3.31
As on 21-Apr-2026 09:30EDT
Market cap
$187 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cost of Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Gross Profit
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Operating Expenses
|
54.43
|
20.11
|
12.43
|
9.46
|
6.88
|
3.21
|
|||||
|
Operating Profit (EBIT)
|
-54.43
|
-20.11
|
-12.43
|
-9.46
|
-6.88
|
-3.21
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
-91.13
|
-42.10
|
-12.20
|
-9.32
|
-8.47
|
-2.21
|
|||||
|
Provision for Tax
|
-10.41
|
-6.19
|
-12.20
|
-0.02
|
-0.23
|
0.83
|
|||||
|
Profit after Tax (Net Income)
|
-80.72
|
-35.92
|
-12.20
|
-9.32
|
-8.47
|
-2.21
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
-8.47
|
-2.21
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
469.80
|
397.93
|
1.31
|
9.13
|
5.54
|
-4.68
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
113.71
|
117.93
|
--
|
--
|
--
|
0.77
|
|||||
|
Current Liabilities
|
1.14
|
3.29
|
2.41
|
1.82
|
1.14
|
4.53
|
|||||
|
Total Liabilities
|
585.80
|
519.15
|
3.72
|
10.95
|
6.69
|
0.62
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
541.57
|
501.76
|
0.12
|
--
|
--
|
0.55
|
|||||
|
Current Assets
|
43.09
|
17.39
|
3.72
|
10.95
|
6.69
|
0.62
|
|||||
|
Total Assets
|
627.74
|
519.15
|
3.72
|
10.95
|
6.69
|
0.62
|
|||||
|
Total Debt*
|
--
|
--
|
--
|
--
|
--
|
2.17
|
|||||
|
Net Current Assets
|
--
|
14.10
|
1.31
|
9.13
|
5.54
|
-3.91
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-16.13
|
-10.90
|
-7.30
|
-6.56
|
-1.09
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-77.57
|
--
|
--
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
107.17
|
3.53
|
11.72
|
13.06
|
0.90
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-2.13
|
-2.13
|
-1.12
|
-6.18
|
-11.91
|
-276.00
|
|||||
|
Cash EPS ($)
|
--
|
--
|
-1.12
|
-6.18
|
-11.91
|
-276.00
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
12.42
|
0.66
|
11.67
|
180.58
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
-0.50
|
-5.52
|
-9.33
|
-213.61
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
-0.50
|
-5.52
|
-9.33
|
-213.61
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
--
|
-17.99
|
-233.69
|
-127.01
|
-560.36
|
|||||
|
ROE (%)
|
-33.92
|
-33.92
|
-17.99
|
-233.69
|
-127.01
|
-1,973.37
|
|||||
|
ROA (%)
|
-25.55
|
-25.55
|
-13.74
|
-166.32
|
-105.69
|
-231.81
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
68.79
|
68.79
|
--
|
-31.27
|
-35.17
|
-326.94
|
|||||
|
Net Profit Growth (%)
|
-546.61
|
-140,524.48
|
-194.45
|
-30.89
|
-9.98
|
-283.99
|
|||||
|
EPS Growth (%)
|
72.70
|
72.70
|
0.82
|
0.48
|
0.96
|
-2.79
|
|||||
|
Book Value Growth (%)
|
814.28
|
814.28
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
-2.70
|
-0.33
|
-0.04
|
0.00
|
|||||
|
Price / Book Value
|
0.50
|
0.50
|
0.24
|
3.06
|
0.04
|
0.00
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-6.32
|
-6.32
|
-1.90
|
-0.04
|
1.15
|
0.98
|
|||||
|
Close Price ($)
|
3.29
|
3.29
|
3.03
|
2.03
|
7.64
|
146.25
|
|||||
|
High Price ($)
|
9.08
|
9.08
|
9.08
|
8.42
|
1,987.50
|
1,590.00
|
|||||
|
Low Price ($)
|
0.95
|
0.95
|
0.95
|
1.84
|
6.45
|
113.63
|
|||||
|
Market Cap ($ Cr)
|
187.37
|
187.37
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
37.75
|
37.75
|
5.29
|
1.54
|
6.03
|
5.84
|
|||||
|
Quick Ratio
|
37.75
|
37.75
|
--
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
-4,584.14
|
-4,584.14
|
--
|
-892.37
|
-563.62
|
-4.32
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|